The COVID-19 pandemic caused by SARS-CoV-2 infection is marked by excessive inflammation of several organs, leading to ...

TPIP trial exceeds expectations; Phase 3 studies to begin by early 2026 Shares in Insmed Incorporated (NASDAQ:INSM) closed 28 ...

Insmed achieved positive phase 2b results for TPIP in PAH, meeting all endpoints and paving the way for phase 3 trials in 2025-2026. Read the latest analysis on the stock here.

A study in Nature Communications reveals, for the first time, how the transcriptomic profile of human tuberculosis lung ...

The agency plans to weaken limits on toxic emissions from power plants while also scrapping restrictions on planet-warming ...

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

From kindergarten to college, each of these milestones is considered a big deal. Channel 9’s Elsa Gillis spoke with one ...

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

Given the probability of trial success and current valuation, we rate the ATYR stock 'Hold' as risk and reward appear ...

LiveLung Augusta is bringing back monthly in-person meetings for lung cancer survivors, patients and caregivers.

Ozone levels and wildfire smoke are expected to worsen the air quality on Wednesday in Allegan, Kent, Muskegon, Ottawa and ...